Modification of the effects of estrogen therapy on HDL cholesterol levels by polymorphisms of the HDL-C receptor, SR-BI: The Rancho Bernardo Study

Atherosclerosis

Volumn 180, Issue 2, 2005, Pages 255-262

  Richard, Erin ^a   Von Muhlen, Denise ^b   Barrett Connor, Elizabeth ^b   Alcaraz, John ^a   Davis, Roger ^c   McCarthy, Jeanette J ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Estrogen therapy; HDL cholesterol; Lipoproteins; Pharmacogenetic; Polymorphism; Scavenger receptor class B type 1

Indexed keywords

ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR BI;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INTRON; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SYMPTOM;

AGED; ANTIGENS, CD36; CHOLESTEROL, HDL; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; EXONS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SEX FACTORS;

EID: 23044480108     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.12.013     Document Type: Article

References (36)

1. G. Samsioe Cardioprotection by estrogens: mechanisms of action - the lipids Int J Fertil Menopausal Stud 39 Suppl 1 1994 43 49
2. J.C. Stevenson, D. Crook, and I.F. Godsland Influence of age and menopause on serum lipids and lipoproteins in healthy women Atherosclerosis 98 1993 83 90
3. F.K. Welty Cardiovascular disease and dyslipidemia in women Arch Intern Med 161 2001 514 522
4. E. Barrett-Connor, and C.A. Stuenkel Hormone replacement therapy (HRT) - risks and benefits Int J Epidemiol 30 2001 423 426
5. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
6. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
7. D.A. Heller, U. de Faire, N.L. Pedersen, G. Dahlen, and G.E. McClearn Genetic and environmental influences on serum lipid levels in twins N Engl J Med 328 1993 1150 1156
8. B.D. Mitchell, C.M. Kammerer, and J. Blangero Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study Circulation 94 1996 2159 2170
9. N. Wang, T. Arai, Y. Ji, F. Rinninger, and A.R. Tall Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice J Biol Chem 273 1998 32920 32926
10. S. Acton, A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs, and M. Krieger Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 271 1996 518 520
11. K.F. Kozarsky, M.H. Donahee, A. Rigotti, S.N. Iqbal, E.R. Edelman, and M. Krieger Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels Nature 387 1997 414 417
12. A. Rigotti, B.L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proc Natl Acad Sci USA 94 1997 12610 12615
13. B. Trigatti, H. Rayburn, and M. Vinals Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology Proc Natl Acad Sci USA 96 1999 9322 9327
14. S. Acton, D. Osgood, and M. Donoghue Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population Arterioscler Thromb Vasc Biol 19 1999 1734 1743
15. J.J. McCarthy, T. Lehner, and C. Reeves Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease J Med Genet 40 2003 453 458
16. J.J. McCarthy, S. Lewitzky, and C. Reeves Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations Hum Hered 55 2003 163 170
17. E.S. Tai, X. Adiconis, and J.M. Ordovas Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia Clin Genet 63 2003 53 58
18. S.H. Hong, Y.R. Kim, Y.M. Yoon, W.K. Min, S.I. Chun, and J.Q. Kim Association between HaeIII polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration Ann Clin Biochem 39 2002 478 481
19. D. von Muhlen, E. Barrett-Connor, and D. Kritz-Silverstein Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use Atherosclerosis 161 2002 209 214
20. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
21. G.A. Rose The diagnosis of ischaemic heart pain and intermittent claudication in field surveys Bull World Health Org 27 1962 645 658
22. J.C. Long, R.C. Williams, and M. Urbanek An E-M algorithm and testing strategy for multiple-locus haplotypes Am J Hum Genet 56 1995 799 810
23. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1996;275:370-5.
24. D.M. Herrington, T.D. Howard, and G.A. Hawkins Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease N Engl J Med 346 2002 967 974
25. N. Srivastava, P.R. Chowdhury, M. Averna, and R.A. Srivastava Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein Mol Cell Biochem 220 2001 87 93
26. K.T. Landschulz, R.K. Pathak, A. Rigotti, M. Krieger, and H.H. Hobbs Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat J Clin Invest 98 1996 984 995
27. H. Stangl, G.A. Graf, L. Yu, G. Cao, and K. Wyne Effect of estrogen on scavenger receptor BI expression in the rat J Endocrinol 175 2002 663 672
28. Y. Ueda, L. Royer, and E. Gong Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice J Biol Chem 274 1999 7165 7171
29. T. Arai, N. Wang, M. Bezouevski, C. Welch, and A.R. Tall Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene J Biol Chem 274 1999 2366 2371
30. Y. Ueda, E. Gong, L. Royer, P.N. Cooper, O.L. Francone, and E.M. Rubin Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics J Biol Chem 275 2000 20368 20373
31. K.F. Kozarsky, M.H. Donahee, J.M. Glick, M. Krieger, and D.J. Rader Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse Arterioscler Thromb Vasc Biol 20 2000 721 727
32. M. Van Eck, J. Twisk, and M. Hoekstra Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver J Biol Chem 278 2003 23699 23705
33. A. Braun, B.L. Trigatti, and M.J. Post Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice Circ Res 90 2002 270 276
34. D. Osgood, D. Corella, and S. Demissie Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the Framingham study J Clin Endocrinol Metab 88 2003 2869 2879
35. R. Durst, R. Colombo, and S. Shpitzen Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews Am J Hum Genet 68 2001 1172 1188
36. W. Yu, A. Nohara, T. Higashikata, H. Lu, A. Inazu, and H. Mabuchi Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population Atherosclerosis 165 2002 335 342